Trimethoprim/sulfamethoxazole prophylaxis impairs function of mobilised autologous peripheral blood stem cells

Bone Marrow Transplantation

Volumn 26, Issue 7, 2000, Pages 815-816

  Fuchs, M ^a   Scheid, C ^a   Schulz, A ^a   Diehl, V ^a   Sohngen, D ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; METHYLCELLULOSE; PREDNISOLONE; STEM CELL FACTOR; VINCRISTINE;

ANTIBIOTIC PROPHYLAXIS; CANCER CHEMOTHERAPY; CASE REPORT; CELL CULTURE; CELL FUNCTION; COLONY FORMATION; COLONY FORMING UNIT GM; HEMATOPOIESIS; HUMAN; LETTER; LEUKAPHERESIS; LEUKOCYTE COUNT; MOBILIZATION; NEUTROPHIL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; STEM CELL;

EID: 0033760549     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702586     Document Type: Letter

References (6)

1. Trimethoprim-associated marrow toxicity
2. Trimethoprim-associated marrow toxicity not proven
3. Trimethoprim marrow toxicity
4. Effect of antimicrobial prophylaxis on hematopoietic recovery following autologous bone marrow transplantation: Ciprofloxacin vs co-trimoxazole
5. Ciprofloxacin vs trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: A randomized, controlled trial
6. + cells for autologous stem cell transplantation significantly reduces febrile complications and usage of antibiotics after transplantation